Skip
UTPhysicians logoUT Physicians - a part of UTHealth
By invitation only, a COVID-19 vaccine is currently available to priority at-risk patients. Learn more.

888-4UT-DOCS | 888-488-3627

  • About Us
    About UT Physicians Careers Contact Us News Health Programs/Services Patient Stories Videos
  • Find a Provider / Clinic
    Search By Specialty Search Providers Search By Name Search By Location
  • Patient Information
    About your Visit Billing Information Clinical Trials Insurance Refer a patient Make an Appointment International Patients Medical Records Legal Billing Records
  • Health Programs/Services
  • Make an Appointment
  • Pay My Bill
  • MyUTP Portal
  • Careers

Simple blood test can predict severity of COVID-19 for some patients

Written by: Jeannette Sanchez | Updated: July 10, 2020
Find a Physician / Clinic
  • Search By Specialty
  • Search Providers
  • Search By Name
  • Search By Location
Researchers at UTHealth have uncovered an early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19. (Photo Credit: Getty Images)

Researchers at UTHealth have uncovered an early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19. (Photo Credit: Getty Images)

An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of Laboratory Hematology.

The severity of COVID-19 infections can range from little or no symptoms for some patients to fighting for their lives in the intensive care unit (ICU) for others. Little is known about what causes these differences.

“Because of the uncertainty surrounding the implications of this virus, we knew there needed to be a prognostic factor that could aid hospital workers in managing COVID-19,” said Ahmad Farooq, MD, corresponding author on the study, and assistant professor of gastroenterology at McGovern Medical School at UTHealth. “In this study, we discovered evidence of a relationship between lymphocytopenia and disease severity that could really help clinicians prepare for critically ill patients.”

Lymphocytopenia is the condition of having an abnormally low levels of white blood cells, called lymphocytes, which are key components of the immune system.

Using a cohort of 57 patients from a local Houston hospital, researchers analyzed basic, clinical, and laboratory data from a simple blood draw and found that patients who were admitted into an ICU showed signs of lymphocytopenia compared to patients who were not in the ICU.

“Lymphocytopenia is known to be common in many viral illnesses, in particular other coronaviruses including Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) and Middle Eastern Respiratory Syndrome coronavirus (MERS-CoV),” said Jason Wagner, MD, lead author on the study and internal medicine resident at McGovern Medical School. “However, few studies have determined if lymphocytopenia found at the time of admission to the hospital is helpful in understanding the course of the disease.”

At the time of hospital admission, patients who ended up in the ICU had lymphocytopenia in comparison to those not needing ICU admission, revealing that blood lymphocyte count could be a predictive marker in identifying who may be admitted into the ICU and suffer severe implications.

Additionally, researchers found that patients with lymphocytopenia were more likely to develop an acute kidney injury (AKI) during admission. According to Farooq, mortality rates are higher in patients who have both COVID-19 and AKI compared to those without AKI.

“The finding of an association with AKI warrants further research. Nevertheless, it is apparent here that lymphocytopenia may serve as a prognostic marker for AKI in patients with COVID-19,” Farooq said.

Additional UTHealth authors include Andrew DuPont, MD, associate professor of gastroenterology; Scott Larson, MD, PhD, assistant professor of gastroenterology; and Brooks Cash, MD, professor and Dan and Lillie Sterling Professor in Clinical Gastroenterology.

The study was funded by the GI Division internal research fund under the guidance of Cash. The GI Division is conducting multiple research projects on COVID-19, including this study.

Media inquiries: 713-500-3030


Share

All Articles
  • Cardiothoracic & Vascular Surgery
  • Children's Health Stories
  • Coronavirus
  • Coronavirus Español
  • COVID-19 Patient Resources
  • Ear, Nose, and Throat Stories
  • Epilepsy
  • Featured
  • Heart Care
  • In the Media
  • In the Media Español
  • News
  • Orthopedics
  • Patient Stories
  • Pediatric Surgery
  • UTHealth COVID-19 Research
  • UTHealth Research
  • Women's Health Stories

UT Physicians A part of UTHealth

UT Professional Building
6410 Fannin Street | Houston, Texas 77030
888-4UT-DOCS (888-488-3627)

UT Physicians - facebook UT Physicians - instagram UT Physicians - twitter UT Physicians - linkedin UT Physicians - youtube

UT PHYSICIANS APP NOW AVAILABLE FOR DOWNLOAD

Downlaod the UT Physicians App on the Apple Store
Downlaod the UT Physicians App on Google Play

AN OFFICIAL ORTHOPEDIC AND SPORTS MEDICINE PROVIDER FOR

Houston Dynamo Logo
Houston Dash Logo

THE CLINICAL PRACTICE OF

McGovern Medical School at UTHealth
Contact / Feedback | Report Error | Patient Privacy | Web File Viewing | Site Policies | Employee Links

Copyright © 2018 to Present – The University of Texas Health Science Center at Houston (UTHealth)